Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.

CONCLUSIONS: The CardioMEMS HF System provided useful information to monitor PAH therapy, and demonstrated short- and long-term safety. Larger clinical trials are needed before its widespread use to guide therapy in severe PAH patients with right-sided HF.
PMID: 31265832 [PubMed - as supplied by publisher]

Source: Chest - June 28, 2019 Category: Respiratory Medicine Authors: Benza RL, Doyle M, Lasorda D, Parikh KS, Correa-Jaque P, Badie N, Ginn G, Airhart S, Franco V, Kanwar M, Murali S, Raina A, Agarwal R, Rajagopal S, White J, Biederman R Tags: Chest Source Type: research